MSCI vs. CME, ICE, IBKR, MCO, NDAQ, MKTX, AROW, PHH, PDD, and MELI
Should you be buying MSCI stock or one of its competitors? The main competitors of MSCI include CME Group (CME), Intercontinental Exchange (ICE), Interactive Brokers Group (IBKR), Moody's (MCO), Nasdaq (NDAQ), MarketAxess (MKTX), Arrow Financial (AROW), PHH (PHH), PDD (PDD), and MercadoLibre (MELI).
MSCI vs. Its Competitors
CME Group (NASDAQ:CME) and MSCI (NYSE:MSCI) are both large-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.
CME Group has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, MSCI has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.
87.8% of CME Group shares are held by institutional investors. Comparatively, 90.0% of MSCI shares are held by institutional investors. 0.3% of CME Group shares are held by company insiders. Comparatively, 3.3% of MSCI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.9%. MSCI pays an annual dividend of $7.20 per share and has a dividend yield of 1.3%. CME Group pays out 50.3% of its earnings in the form of a dividend. MSCI pays out 49.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MSCI has increased its dividend for 11 consecutive years.
CME Group currently has a consensus price target of $258.20, suggesting a potential downside of 4.25%. MSCI has a consensus price target of $645.36, suggesting a potential upside of 16.47%. Given MSCI's stronger consensus rating and higher possible upside, analysts clearly believe MSCI is more favorable than CME Group.
In the previous week, CME Group had 5 more articles in the media than MSCI. MarketBeat recorded 27 mentions for CME Group and 22 mentions for MSCI. CME Group's average media sentiment score of 1.28 beat MSCI's score of 0.87 indicating that CME Group is being referred to more favorably in the media.
CME Group received 122 more outperform votes than MSCI when rated by MarketBeat users. However, 65.99% of users gave MSCI an outperform vote while only 58.57% of users gave CME Group an outperform vote.
CME Group has higher revenue and earnings than MSCI. CME Group is trading at a lower price-to-earnings ratio than MSCI, indicating that it is currently the more affordable of the two stocks.
CME Group has a net margin of 57.52% compared to MSCI's net margin of 38.83%. CME Group's return on equity of 13.62% beat MSCI's return on equity.
Summary
MSCI beats CME Group on 12 of the 21 factors compared between the two stocks.
Get MSCI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MSCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MSCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:MSCI) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy MSCI Stock Free MSCI Stock Alerts